Materials Healthcare Sector

Elicio Therapeutics

Market Cap: US$82.1m

A clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer.

Imugene

Market Cap: AU$126.9m

A clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia.

Arch Biopartners

Market Cap: US$81.7m

Engages in the development of novel drugs for acute kidney injury and organ damage in Canada.

TScan Therapeutics

Market Cap: US$81.5m

A clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States.

Climb Bio

Market Cap: US$81.1m

A clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases.

Galectin Therapeutics

Market Cap: US$81.0m

A clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases.

SomnoMed

Market Cap: AU$124.3m

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe.

Champions Oncology

Market Cap: US$79.6m

A technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States.

Senti Biosciences

Market Cap: US$79.5m

A clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases.

Alto Neuroscience

Market Cap: US$79.3m

Operates as a clinical-stage biopharmaceutical company in the United States.

Paradigm Biopharmaceuticals

Market Cap: AU$122.7m

Engages in the research and development of therapeutic products for human use in Australia.

IO Biotech

Market Cap: US$79.1m

A clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform.

Genenta Science

Market Cap: US$78.6m

A clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy.

NetraMark Holdings

Market Cap: CA$106.5m

Develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada.

Quipt Home Medical

Market Cap: CA$106.4m

Through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States.

Sensus Healthcare

Market Cap: US$77.2m

Operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide.

Adagene

Market Cap: US$76.6m

A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.

Kooth

Market Cap: UK£56.5m

Provides digital mental health services to children, young people, and adults in the United Kingdom.

Sutro Biopharma

Market Cap: US$76.2m

Operates as a oncology company.

Cumberland Pharmaceuticals

Market Cap: US$76.2m

A specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally.

e-therapeutics

Market Cap: US$76.0m

Engages in drug discovery research activities in the United Kingdom.

Milestone Scientific

Market Cap: US$75.8m

A biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally.

4DMedical

Market Cap: AU$117.1m

Operates as a medical technology company in the United States and Australia.

Pyxis Oncology

Market Cap: US$74.3m

A clinical stage company, engages in the development of therapeutics to treat solid tumors.

TRUBAR

Market Cap: CA$101.9m

Simply Better Brands Corp. operates as a consumer products company with diversified assets in the plant-based and wellness consumer product categories in Canada.

Inovio Pharmaceuticals

Market Cap: US$74.1m

A biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.

ESSA Pharma

Market Cap: US$73.7m

A clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.

CervoMed

Market Cap: US$73.3m

A a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders.

Jasper Therapeutics

Market Cap: US$73.2m

A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases.

Adaptimmune Therapeutics

Market Cap: US$72.7m

A commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom.

Inotiv

Market Cap: US$72.5m

Provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally.

IGM Biosciences

Market Cap: US$72.1m

A biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases.

Nuo Therapeutics

Market Cap: US$72.1m

Operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States.

Veru

Market Cap: US$71.8m

A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS).

PDS Biotechnology

Market Cap: US$71.3m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies.

Sera Prognostics

Market Cap: US$70.8m

A women’s health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States.